Dr. Davis holds positions as a Professor in both Cardiology and Biomedical Engineering at the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. Additionally, he serves as an associate chair for graduate studies at BME department, and a director of the Children's Heart Research and Outcomes (HeRO) Center. He received his Ph.D. in Molecular and Systems Pharmacology at Emory University in 2003 working on molecular regulation of eNOS expression by shear stress. From 2003-2006, he completed his postdoctoral fellowship at Brigham and Women's Hospital working on cardiac tissue engineering with collaborators at the Massachusetts Institute of Technology. He moved back to Emory in 2006 to join the faculty in Division of Cardiology and Biomedical Engineering Department.

Dr. Rafael Davalos' research interests are in microfluidics for personalized medicine and developing technologies for cancer therapy. He is most recognized for co-inventing Irreversible Electroporation (IRE), a minimally invasive non-thermal surgical technique to treat unresectable tumors near critical structures such as major blood vessels and nerves. The technology has been used to help thousands of patients worldwide with a second-generation version in clinical trials. Davalos has authored 150 peer-reviewed articles and has 47 issued patents (72 h-index, >18,000 citations) and has secured over $37M in research funding with $10M his share. His patents have been licensed to 7 companies. He has been a plenary speaker for several prestigious venues including the International Symposium of the Bioelectrochemistry Society, the World Congress on Electroporation, and the Society of Cryobiology Annual Meeting. 

Lakshmi Prasad Dasi is an established researcher in the field of prosthetic heart valves, cardiovascular biomechanics, biomaterials, and devices. He is currently a tenure Professor of Biomedical Engineering, at Georgia Institute of Technology while holding the Rozelle Vanda Wesley Endowed Professorship as well as being the Associate Chair for Undergraduate Studies. He has held positions at The Ohio State University, and Colorado State University previously. He is a Fellow of the American College of Cardiology (FACC) as well as Fellow of the American Institute for Medical and Biological Engineering (FAIMBE). 

Dasi earned his Ph.D. from Georgia Institute of Technology in 2004 with a focus in fluid dynamics and turbulence. He trained as a postdoctoral fellow and research engineer under Prof. Ajit Yoganathan’s mentorship at Georgia Tech where he transformed his research focus to heart valves, devices, and cardiovascular biomechanics. In 2009, he established the Cardiovascular Biofluid Mechanics Lab (CBFL) as Assistant Professor at Colorado State University and moved to The Ohio State University in 2015 as his focus became more translational. Since 2020, his research at Georgia Tech focuses on tackling the complexity of: (a) heart valve biomechanics (native and prosthetic); (b) prosthetic heart valve engineering (conventional & trans-catheter); (c) structure-function relationships of the heart in health and disease at the embryonic, pediatric, as well as adult stages; and (d) turbulence and turbulent blood flow.

Scott Danielsen is an Assistant Professor in the School of Materials Science and Engineering at the Georgia Institute of Technology. He obtained his Ph.D. in chemical engineering at the University of California, Santa Barbara in 2018 and his B.S.E. in chemical and biomolecular engineering at the University of Pennsylvania in 2014. He then spent five years as a postdoctoral associate at Duke University and as a visiting scholar at the University of North Carolina School of Medicine from 2019-2023. 

Prof. Danielsen’s group uses a combination of theoretical, computational, and experimental methods to reveal structure–property–processing relationships of soft materials. Their current primary research interests are the structure and dynamics of nonideal structured fluids, particularly polymer gels and biological fluids, with a focus on designing new materials and processing conditions for functional materials.

The effortlessness of moving your body belies the lurking complexity driving it. We are trying to understand how the nervous system makes something so complicated as controlling a human body feel so natural. We use human subjects studies, animal experiments, mathematical biology, and artificial intelligence to understand neural control of movement. New theories and insight promise advances in physical therapy, human-machine collaboration, brain-computer interfaces, neural modulation of peripheral reflexes, and more.

Aditi Das did her BSc. (Hons.) Chemistry from St. Stephen's College Delhi, followed by M.S. (Chemistry) from I.I.T (Kanpur). She received her Ph.D. in Chemistry from Princeton University. She did post-doctoral work with Prof. Steve Sligar. She joined University of Illinois, Urbana-Champaign (UIUC) as a tenure track assistant professor in 2012. In 2019, she was promoted to associate professor with tenure. In 2022, she joined School of Chemistry and Biochemistry at Georgia Institute of Technology as an associate professor with tenure. Her research is in the area of enzymology of oxygenases that are involved lipid metabolism and cannabinoid metabolism.

Das is recipient of an American Heart Associate (AHA) career award and has been funded by National Institute of Health (NIH - NIGMS, NIDA and NCCIH), USDA, and National Multiple Sclerosis Society (NMSS). Her research was recognized by several National awards: Young Investigator award From Eicosanoid Research Foundation, Mary Swartz Rose Young Investigator Award and E.L.R. Stokstad award from American Society for Nutrition (ASN) for outstanding research on bioactive compounds for human health. She is also the recipient of Zoetis Research Excellence Award from her college. She was a co-organizer of the International Conference on Cytochrome P450. Recently her laboratory contributed several papers on cannabinoid metabolism by p450s. In recognition of this work, she was awarded El Sohly award from the ACS-Cannabis division for excellence in Cannabis research and is invited to give plenary lecture at ISSX meeting.  Das is also a standing study section member of BBM NIH study section. 

Nate Damen is a Research Engineer I with Aerospace, Transportation and Advanced Systems Laboratory of Georgia Tech Research Institute. Damen’s work at ATAS has focused on Mixed Reality applications, robotics, the automation of CAR-T cellular expansions, and bioreactor design. Before joining GTRI, Damen conducted research into the manipulation of textiles with Softwear Automation and the design of deformable parcel manipulation systems with Dorabot. His creative work ATLTVHEAD with the Atlanta Beltline Inc., includes the creation of several wearable electronic systems for remote computing and novel interactions between wearable systems and live user input from those walking the Atlanta Beltline. 

Sheng Dai, Ph.D., P.E., earned his degrees from Tongji University and Georgia Tech. He worked as an ORISE postdoc at the National Energy Technology Laboratory of the U.S. Department of Energy, and returned to Georgia Tech as a faculty member in 2015. He is currently an associate professor in the School of Civil and Environmental Engineering, Ocean Science and Engineering. and holds a courtesy appointment at the School of Earth and Atmospheric Sciences at Georgia Tech.

Dr. Dai's group addresses emerging energy and environment challenges through studying subsurface geomechanics, geomaterials characterization, energy geotechnics, bio-inspired geotechnics, flow in porous media, and granular dynamics. His research has been funded by federal funding agencies (DOE, NSF, NASA, DOT), national labs (INL, NETL), and industry (AECOM, GTI, Leidos).  Dr. Dai has been recognized for his research and teaching, including being a recipient of the NSF CAREER award, the ORISE Fellowship, the Bill Schutz Junior Faculty Teaching Award, and the Class of 1969 Teaching Fellows at Georgia Tech.

He is an associated editor of the Journal of Geophysical Research: Solid Earth and Advances in Geo-Energy Research, an editorial advisor of Geomechanics for Energy and Environment, and serves on the Pressure Core Advisory Board for U.S. Geological Survey, the GOM2 Marine Test Technical Advisory Committee for UT/DOE, the National Gas Hydrate Program for NETL, and the Task Force Leader of TC308 Energy Geotechnics of ISSMGE. 

James Dahlman is a bioengineer / molecular engineer whose work lies at the interface of chemistry, nanotechnology, genomics, and gene editing. His lab focuses on targeted drug delivery, in vivo gene editing, Cas9 therapies, siRNA therapies, and developing new technologies to improve biomaterial design. 

The DahlmanLab is known for applying 'big data' technologies to nanomedicine. The lab is pioneering DNA barcoded nanoparticles; using DNA barcodes, >200 nanoparticles can be analyzed simultaneously in vivo. These nanoparticles are studied directly in vivo, and used to deliver targeted therapies like siRNA, mRNA, or Cas9. As a result of this work, James was named 1 of the 35 most innovative people under the age of 35 by MIT Technnology Review in 2018. James has won many national / international awards, and has published in Science, Nature Nanotechnology, Nature Biotechnology, Nature Cell Biology, Cell, Science Translational Medicine, PNAS, JACS, ACS Nano, Nano Letters, and other journals. James has also designed nanoparticles that efficiently deliver RNAs to the lung and heart. These nanoparticles can deliver 5 siRNAs at once in vivo, and are under consideration for clinical development. As a result, the lab has an interest in immunology and vascular biology. 

James supports entirely new research students come up with independently. To this end, DahlmanLab students learn how to (i) generate new ideas, (ii) select the good ones, and (iii) efficiently test whether the good ideas will actually work. 

Dahlman Lab students learn how to design/characterize/administer nanoparticles, how to isolate different cell types in vivo, how to rationally design DNA to record information, Cas9 therapies, and deep sequencing. As a result, the lab is an interdisciplinary group with students that have backgrounds in medicinal chemistry, BME, bioinformatics, biochemistry, and other fields. The lab welcomes students with all types of scientific backgrounds. The lab firmly stands by students, independent of their personal beliefs, preferences, or backgrounds.